Comparison of total plasma lysophosphatidic acid and serum CA-125 as a tumor marker in the diagnosis and follow-up of patients with epithelial ovarian cancer - Concepedia

Concepedia

Publication | Open Access

Comparison of total plasma lysophosphatidic acid and serum CA-125 as a tumor marker in the diagnosis and follow-up of patients with epithelial ovarian cancer

DOI Full Paper Access

44

Citations

32

References

2010

Year

Tugan Beşe, Merve Barbaros, Elif Baykara, Onur Güralp, Sali̇h Cengi̇z, Fuat Demirkıran, C. Şanioǧlu, Macit Arvas

Journal of Gynecologic Oncology

Abstract

LPA is a better biomarker for diagnosis of epithelial ovarian cancer compared to CA-125. However, measurement of total plasma LPA levels during chemotherapy administration have no superiority to the serum CA-125 levels.

References

	Year	Citations

Page 1